SPONSOR
Pheast Therapeutics
Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Advanced Solid TumorsOvarian CancerEndometrial CancerCholangiocarcinomaCNS Tumor
Pheast Therapeutics is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Advanced Solid Tumors, Ovarian Cancer, Endometrial Cancer, Cholangiocarcinoma.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Pheast Therapeutics
How many clinical trials has Pheast Therapeutics sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Pheast Therapeutics, of which 1 are actively recruiting participants. These trials cover conditions including Advanced Solid Tumors, Ovarian Cancer, Endometrial Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Pheast Therapeutics research focus on?
Pheast Therapeutics clinical trials span Advanced Solid Tumors, Ovarian Cancer, Endometrial Cancer, Cholangiocarcinoma, CNS Tumor. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Pheast Therapeutics clinical trial?
To participate in a Pheast Therapeutics trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Pheast Therapeutics trials with current recruitment status updated daily.
Clinical Trials by Pheast Therapeutics
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology